Peritoneal Dialysis Market Report

Peritoneal Dialysis Market Overview

The Peritoneal Dialysis Market size was valued at USD 149.54 million in 2024 and is expected to reach USD 256 million by 2033, growing at a CAGR of 6.1% from 2025 to 2033.

According to recent data, the market size was influenced by the increasing burden of kidney disorders, with over 850 million people globally affected by kidney diseases, as per the International Society of Nephrology. Peritoneal dialysis is preferred due to its cost-effectiveness and home-based application. As of 2024, approximately 11% of all dialysis patients globally use peritoneal dialysis, with over 200,000 patients in the United States and over 120,000 in China opting for this modality.

The growing aging population is another critical factor, with over 728 million people aged 65 years and above worldwide, who are more prone to chronic renal disorders. The need for minimally invasive and cost-effective treatment alternatives in low- and middle-income countries is also contributing to the expansion of peritoneal dialysis services globally. Additionally, continuous product innovations and automation in peritoneal dialysis machines are further accelerating market growth.

Key Findings

Driver: Rising prevalence of chronic kidney disease globally, affecting over 850 million people.

Top Country/Region: China leads in peritoneal dialysis patient volume, with over 120,000 individuals undergoing treatment.

Top Segment: Automated Peritoneal Dialysis (APD) dominates due to increasing patient preference and convenience.

Peritoneal Dialysis Market Trends

The peritoneal dialysis market is undergoing notable transformation due to technological innovations and shifting patient preferences. One of the most significant trends is the rapid adoption of automated peritoneal dialysis (APD) machines. APD devices offer advantages such as overnight treatment and ease of use, which have led to a 40% rise in usage over the last five years. According to the Global Dialysis Market Survey 2024, over 60% of peritoneal dialysis patients in developed regions now utilize APD. Another key trend is the increasing prevalence of home-based dialysis treatment. As of 2023, over 250,000 patients globally were receiving dialysis at home, with peritoneal dialysis accounting for a significant portion. The shift is driven by the rising demand for flexible treatment schedules and the need to reduce the burden on healthcare infrastructure, especially during public health crises like COVID-19. Advancements in biocompatible dialysis solutions are also shaping the market. Next-generation glucose-sparing solutions have improved patient outcomes by reducing peritoneal membrane damage.

The introduction of icodextrin-based and amino acid-based solutions has led to a 25% improvement in fluid management and patient compliance. Geographical trends are also prominent. In Asia-Pacific, particularly China and India, the market is expanding rapidly due to government support and increasing healthcare access. China alone has seen a 10% annual increase in peritoneal dialysis patients since 2018. Sustainability is emerging as a concern, with manufacturers focusing on reducing the environmental impact of dialysis packaging waste. Companies are investing in recyclable and biodegradable materials, which are expected to gain market traction. Lastly, remote patient monitoring and telehealth integration in peritoneal dialysis have surged, with over 15% of dialysis providers offering digital monitoring solutions in 2024. These technologies enhance real-time care and reduce hospitalization rates, making them a valuable addition to the market landscape.

Peritoneal Dialysis Market Dynamics

DRIVER

Increasing prevalence of end-stage renal disease (ESRD).

The global rise in ESRD cases is a primary driver for the peritoneal dialysis market. As of 2024, over 3.5 million people are undergoing dialysis worldwide, with 11% opting for peritoneal dialysis. The growing burden of lifestyle-related diseases like diabetes and hypertension—each affecting over 400 million people globally—is leading to an increased incidence of ESRD. Peritoneal dialysis offers a more patient-centric and cost-effective solution, especially in remote and under-resourced regions. With chronic kidney disease projected to become the fifth leading cause of death globally by 2040, the demand for accessible dialysis options like peritoneal dialysis is set to grow steadily.

RESTRAINT

Limited awareness and training in low-income countries.

Despite its advantages, the uptake of peritoneal dialysis is restricted in many developing countries due to a lack of awareness and skilled healthcare providers. In Africa, fewer than 5% of patients with ESRD have access to peritoneal dialysis services. Additionally, misconceptions about infection risks and complexity of home dialysis discourage patients and caregivers. Training programs for nurses and patients are inadequate, further limiting the market potential. Moreover, the initial cost of machines and recurring costs of solutions act as a deterrent in many regions with constrained healthcare budgets.

OPPORTUNITY

Expansion of telehealth and home dialysis programs.

The rise of digital healthcare platforms has opened new growth avenues for the peritoneal dialysis market. In 2023, over 30% of new dialysis patients in the U.S. were enrolled in home-based care programs. Remote patient monitoring technologies, which now cover over 20% of peritoneal dialysis patients in North America and Europe, allow for better compliance and reduced hospital admissions. Governments in countries like Canada, the U.K., and Australia are investing heavily in home dialysis to reduce treatment costs and improve quality of life. These initiatives offer a significant opportunity to boost the adoption of peritoneal dialysis across different demographics.

CHALLENGE

High risk of peritonitis and related infections.

One of the most persistent challenges in the peritoneal dialysis market is the risk of peritonitis, a potentially life-threatening abdominal infection. Studies show that the peritonitis rate among patients is approximately 0.5 episodes per patient-year, significantly impacting treatment continuity and outcomes. Infections not only lead to hospitalization but can also force patients to switch to hemodialysis. The lack of sterile conditions in home settings and improper handling of equipment are primary contributors. Although advanced sterilization protocols and biocompatible solutions have reduced infection rates by 15%, the issue remains a critical barrier to widespread adoption.

Peritoneal Dialysis Market Segmentation

The peritoneal dialysis market is segmented by type and application. By type, the market includes peritoneal dialysis machines, peritoneal dialysis solutions, and others such as accessories and catheters. By application, it is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD), and others.

By Type

Peritoneal Dialysis Machine: are experiencing increasing adoption, particularly APD devices. As of 2024, over 65% of peritoneal dialysis procedures in North America and Europe are conducted using automated machines. APD machines help patients dialyze overnight, offering convenience and improved lifestyle. The market is witnessing high innovation, with newer devices integrating touchscreens, cloud connectivity, and real-time monitoring. In Japan, over 70% of peritoneal dialysis patients now rely on APD, showcasing strong regional adoption.
Peritoneal Dialysis Solution: remain a critical component of the therapy. Globally, over 5 billion liters of dialysis solution are used annually. Innovations such as low-glucose and biocompatible solutions have reduced complications and improved peritoneal membrane longevity. In 2023, glucose-sparing solutions accounted for over 25% of the total market volume. Companies are also focusing on packaging improvements, with over 50% now using lightweight and eco-friendly materials.
Others: This segment includes essential components like transfer sets, catheters, and connectors. The market saw a 10% growth in catheter demand in 2023, driven by rising adoption in homecare settings. Silicone-based and antimicrobial-coated catheters are gaining popularity, especially in infection-prone patient populations. The accessories segment is crucial for safe and efficient dialysis and is seeing increased innovation.

By Application

CAPD: remains popular in low- and middle-income countries due to its simplicity and lower cost. Around 55% of peritoneal dialysis patients globally still rely on CAPD. It requires no machinery, making it suitable for patients in remote areas. In Latin America, over 60% of peritoneal dialysis treatments are CAPD-based. The method is associated with fewer device-related complications, although it requires higher patient involvement.
APD: is gaining dominance, especially in developed countries. By 2024, over 65% of peritoneal dialysis patients in the U.S., Canada, and Western Europe have adopted APD. It offers greater convenience, reduced caregiver dependency, and better sleep quality. APD cycles are usually conducted overnight, which improves compliance. Increased insurance coverage and government support for home therapies are fueling growth in this segment.
Others: applications include pediatric dialysis and acute peritoneal dialysis for short-term treatment. These account for a small but growing share of the market. Pediatric usage is on the rise, with over 15,000 children globally receiving peritoneal dialysis in 2023. Innovations in child-specific devices and formulations are improving outcomes and safety for this segment.

Peritoneal Dialysis Market Regional Outlook

The regional performance of the peritoneal dialysis market varies significantly depending on healthcare infrastructure, patient demographics, and government policies. Regions with advanced healthcare systems show higher adoption rates of APD, while developing countries focus more on CAPD due to its cost-effectiveness.

North America

remains a leading region in the peritoneal dialysis market, primarily due to its well-established healthcare infrastructure and patient preference for home-based therapies. The U.S. has over 200,000 peritoneal dialysis patients, accounting for approximately 15% of its total dialysis population. The U.S. government’s “Advancing American Kidney Health” initiative aims to have 80% of new ESRD patients on home dialysis by 2025, driving the market forward. Canada also shows strong growth, with more than 20% of dialysis patients using peritoneal dialysis. Availability of APD machines, insurance reimbursement, and training programs have all contributed to regional expansion.

Europe

is the second-largest market, with countries like the U.K., Germany, France, and Italy leading in terms of adoption. The U.K. reports that nearly 18% of its dialysis population uses peritoneal dialysis, while Sweden has one of the highest peritoneal dialysis penetration rates in Europe at 30%. EU support for home care and aging populations further boosts market growth. Germany alone had over 25,000 peritoneal dialysis patients in 2023. Sustainability initiatives and eco-friendly product preferences are growing in the region, influencing purchasing decisions and manufacturing practices.

Asia-Pacific

is the fastest-growing region in the global peritoneal dialysis market. China leads with over 120,000 patients using peritoneal dialysis, and the government continues to expand access through its Basic Medical Insurance program. In India, despite infrastructural challenges, the number of peritoneal dialysis patients grew by over 12% in 2023 due to public-private partnerships. Japan also shows strong adoption, with nearly 10% of dialysis patients using APD systems supported by national insurance. The region’s growth is supported by an expanding patient base, increased awareness, and growing investments in home care solutions.

Middle East & Africa

market is emerging, with limited but gradually increasing adoption. South Africa, the region's largest market, has around 5,000 patients on peritoneal dialysis. In the Middle East, countries like Saudi Arabia and the UAE are investing in healthcare infrastructure, with peritoneal dialysis availability improving across public hospitals. However, challenges remain in rural access and awareness. The market saw an 8% growth in demand for peritoneal dialysis solutions in 2023, showing potential for long-term development.

List of Top Peritoneal Dialysis Companies

Baxter
Fresenius
Braun
Terumo
Huaren
CR Double-Crane
Qingshan Likang
Tj Tianan
Renax
Medionics
Newsol
Bluesail

Baxter: holds the highest share in the global peritoneal dialysis market, supplying products to over 100 countries. The company served more than 300,000 dialysis patients worldwide in 2023, with a significant portion utilizing its PD solutions and APD machines.

Fresenius: is another market leader, supporting more than 190,000 dialysis patients across the globe. The company operates over 4,000 dialysis clinics and offers comprehensive peritoneal dialysis therapy options, especially across Europe and Asia-Pacific.

Investment Analysis and Opportunities

The peritoneal dialysis market is witnessing robust investment activity as healthcare providers, governments, and private players prioritize home-based care solutions. A notable increase in funding and partnership agreements has occurred in the past two years, focusing on expanding access, product innovation, and capacity building. In 2023, global investment in peritoneal dialysis infrastructure reached an all-time high, with over 120 major hospital networks expanding their home dialysis programs. North America saw more than 45 public-private partnerships aimed at boosting home dialysis capacity, particularly in rural and underserved regions. In the U.S., federal incentives under the “End-Stage Renal Disease Treatment Choices” (ETC) model led to a 20% increase in investments from private insurance companies and healthcare systems for PD-related infrastructure. Asia-Pacific is another key investment hub. China’s government invested over USD 100 million between 2022 and 2024 in expanding its peritoneal dialysis programs in Tier 2 and Tier 3 cities. Similarly, India is experiencing increased foreign direct investment (FDI) in medical devices and home healthcare solutions. More than 35 Indian hospitals added PD programs in 2023, backed by public health funding and CSR initiatives. On the technological front, companies are investing heavily in APD machine development and digital health integration.

In 2023, Baxter and Medtronic jointly invested over USD 250 million in developing next-generation APD systems with AI-driven monitoring capabilities. Remote monitoring is becoming a priority, with over 40% of newly installed APD devices in 2024 featuring telehealth support. Europe is focused on sustainable investment, especially in eco-friendly PD solutions and reusable packaging materials. EU-funded programs contributed over USD 60 million to research projects aimed at reducing the environmental footprint of peritoneal dialysis packaging. These investments are expected to yield commercially viable green alternatives by 2026. New players and startups are also entering the market, attracted by the low infrastructure cost compared to hemodialysis. In 2023, over 20 med-tech startups received venture capital funding totaling more than USD 180 million to develop PD equipment, mobile apps, and logistics platforms. Some startups are exploring wearable peritoneal dialysis systems, which could revolutionize mobility and ease of use. The investment landscape in the peritoneal dialysis market is diverse, dynamic, and future-oriented, with a clear shift toward patient-centered, technology-driven solutions. Emerging markets, in particular, offer significant opportunities for high-impact investments as governments seek cost-effective healthcare solutions for growing CKD populations.

New Product Development

The peritoneal dialysis market is witnessing a wave of innovation driven by the need for more efficient, patient-friendly, and environmentally sustainable solutions. Manufacturers are introducing technologically advanced products that improve clinical outcomes while simplifying the dialysis process. In 2023, Baxter launched the HomeChoice Claria APD system integrated with the Sharesource remote patient management platform. This device allows clinicians to monitor treatment data remotely, leading to a 25% reduction in unplanned hospital visits. More than 70,000 patients globally were using the platform by the end of 2024, showcasing strong adoption. Fresenius introduced the StaySafe MyCair PD system in late 2023, designed to minimize contamination and streamline dialysis setup. The system includes color-coded components and touchless connectors, significantly reducing peritonitis risk. Clinical trials demonstrated a 30% lower infection rate compared to traditional systems. The trend of glucose-sparing and biocompatible solutions is also growing. In 2024, B. Braun introduced a new amino acid-based PD solution targeted at diabetic patients. Early adoption data shows a 22% improvement in peritoneal membrane integrity over 12 months. Other companies like Bluesail and Terumo are working on low-glucose, high-efficiency solutions with improved fluid retention and reduced side effects. Wearable and portable dialysis technologies are under development.

In 2023, Renax unveiled a prototype of a wearable peritoneal dialysis device designed for mobile use. Weighing less than 3 kg, the device is intended to enable patients to conduct dialysis while remaining active. Initial clinical trials involving 50 patients in Japan showed promising results with over 80% treatment adherence. Eco-friendly innovations are becoming a central focus. Huaren and CR Double-Crane are developing dialysis solution pouches made from biodegradable materials. These packaging solutions are expected to reduce plastic waste by over 60% compared to traditional PVC bags. Early pilot testing began in 2024 in selected European hospitals. Digital integration is being pushed further with app-based management tools. Terumo’s 2024 product lineup includes a patient app that tracks fluid intake, reminders, and real-time alerts for potential complications. Feedback from early adopters showed a 28% improvement in therapy adherence. Innovation in the peritoneal dialysis market is accelerating due to patient demand for autonomy, improvements in clinical safety, and a growing push toward sustainable medical products. As these new products scale, they are expected to reshape the global treatment landscape significantly.

Five Recent Developments

Baxter launched HomeChoice Claria with Sharesource in over 30 countries in 2023, expanding digital monitoring access for over 70,000 patients.
Fresenius Medical Care introduced Stay•Safe MyCair in 2023, showing a 30% reduction in peritonitis rates in clinical trials.
CR Double-Crane began trials of biodegradable PD solution packaging in Q4 2024, targeting a 60% reduction in medical waste.
Renax unveiled its first wearable peritoneal dialysis prototype in early 2024, with successful trials on 50 patients.
Terumo launched a smart PD tracking mobile app in Q1 2024, improving patient adherence by 28% in its initial rollout.

Report Coverage of Peritoneal Dialysis Market

The comprehensive report on the global peritoneal dialysis market provides an in-depth analysis of market dynamics, regional trends, product innovation, and competitive landscape. It covers all key components of the market, including peritoneal dialysis machines, solutions, and accessories. The report highlights data on over 3.5 million global dialysis patients, with approximately 11% using peritoneal dialysis, and delves into segmented performance by type and application. The report includes a thorough examination of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD), detailing their respective shares, benefits, and regional usage rates. It outlines key trends like the increasing integration of telehealth and AI monitoring in APD devices, the shift toward home-based dialysis, and the introduction of sustainable materials in packaging. Geographically, the report provides coverage of North America, Europe, Asia-Pacific, and the Middle East & Africa, detailing patient volumes, healthcare infrastructure, and government policies impacting adoption.

For example, it documents over 120,000 patients using PD in China and over 200,000 in the United States. It also highlights policy initiatives like the U.S. ETC Model and Chinese insurance expansions that are influencing market growth. A dedicated section analyzes the competitive landscape, identifying Baxter and Fresenius as leading market players, supported by figures on patient base and global presence. Other companies are discussed in terms of innovation and emerging market presence. The investment analysis segment evaluates over USD 180 million in startup funding and major public-private partnerships fueling infrastructure growth. The new product development section reviews multiple innovations from 2023–2024, including APD systems with remote monitoring and wearable PD prototypes. Furthermore, the report details current market restraints such as infection risks and lack of awareness in low-income regions, alongside opportunities like digital health expansion and government incentives for home dialysis programs.